Globally, pancreatic cancer ranks 12th in terms of incidence but sixth for mortality signifying its aggressive behavior and limited treatment options. While the mortality rates for many other solid ...

Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...

Abrogation of the serum GAS6 by batiraxcept suggests that the AXL-GAS6 pathway can be inhibited in pancreatic cancer and warrants further evaluation in patients ... phase Ib trial for patients with ...

Pancreatic cancer (PC) is a highly aggressive disease ... Hereditary pancreatitis (HP) is a rare genetic disorder characterized by recurrent acute pancreatitis and chronic pancreatitis that ...

Rich and Duff 5 have also produced evidence of pancreatitis resulting from intra-pancreatic obstruction. Since 1952 we have operated on 53 patients with recurrent pancreatitis, directing our ...

He developed pancreatic cancer in 2020, when he was in his late 40s. 08:40 The tumor was already 4.5 centimeters in size, and had become intertwined with blood vessels, making it inoperable.

Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions" report has been added to ResearchAndMarkets.com's offering. Both ...